| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.083 | 0.6 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |